T. Rowe Price Associates’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

T. Rowe Price Associates’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-31,500	Closed	-$93K	–	2684
2017 Q3	$93K	Hold	31,500	–	–	﹤0.01%	2501
2017 Q2	$88K	Hold	31,500	–	–	﹤0.01%	2496
2017 Q1	$60K	Hold	31,500	–	–	﹤0.01%	2531
2016 Q4	$55K	Hold	31,500	–	–	﹤0.01%	2517
2016 Q3	$85K	Hold	31,500	–	–	﹤0.01%	2464
2016 Q2	$74K	Sell	31,500 -100	-0.3%	-$276	﹤0.01%	2459
2016 Q1	$102K	Hold	31,600	–	–	﹤0.01%	2413
2015 Q4	$151K	Buy	+31,600	New	+$179K	﹤0.01%	2357

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

T. Rowe Price Associates's BDSI Position: Q4 2017 in Review

T. Rowe Price Associates sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2017, closing a stake of 31,500 shares — an estimated $93K sold.

T. Rowe Price Associates first reported a position in BDSI in Q4 2015 and held it in 8 quarters. The position peaked at $151K in Q4 2015. 70 funds tracked by Wall St. Rank hold BDSI as of Q4 2017.

T. Rowe Price Associates reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2017 after selling out during the quarter.
T. Rowe Price Associates sold 31,500 BioDelivery Sciences International, Inc. shares in Q4 2017, an estimated $93K.
T. Rowe Price Associates first reported a position in BioDelivery Sciences International, Inc. in Q4 2015 and held it in 8 quarters.
T. Rowe Price Associates's BioDelivery Sciences International, Inc. position peaked at $151K in Q4 2015.
70 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2017.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.